RxDoctor Payments Data
★ My doctorsLook up a doctor →

Ehab Kodsi

Physical Medicine & Rehabilitation · Queensbury, NYNPI 1063594752

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 655 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 43 manufacturers reported payments, led by AbbVie at 28.1% of the total. Reporting peaked in 2022 at $2,523 and has fallen 98.8% since, to $31 in 2025. Among physical medicine & rehabilitation clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,114in general payments, 2019–2025

Across 655 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Amgen$1K
  • Collegium Pharmaceutical, Inc.$519
  • Pfizer$472
  • Scilex Pharmaceuticals Inc.$446
  • Merz Pharmaceuticals, LLC$425
  • plus $5K from 37 others

What the payments were for

  • Food & beverage$11,110100%
  • Education$40%
  • Gifts$00%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)198$3,128
Amgen(2 entities)59$1,135
Collegium Pharmaceutical, Inc.38$519
Pfizer30$472
Scilex Pharmaceuticals Inc.25$446
Merz Pharmaceuticals, LLC12$425
Arbor Pharmaceuticals, Inc.27$413
Supernus Pharmaceuticals, Inc.22$373
Biohaven Pharmaceutical Holding Company Ltd.22$345
Teva Pharmaceuticals USA, Inc.20$305
Biohaven Pharmaceuticals, Inc.14$289
Kowa Pharmaceuticals America, Inc.15$276
Lilly USA, LLC11$216
GRT US Holding, Inc.10$212
Ipsen Biopharmaceuticals, Inc11$202
Johnson & Johnson9$192
Novo Nordisk10$169
Fidia Pharma USA Inc.11$169
Lundbeck LLC8$163
Azurity Pharmaceuticals, Inc.18$156
Merz North America, Inc.17$145
Impel Pharmaceuticals Inc.7$142
MDD US Operations, LLC9$135
Pacira Therapeutics, Inc.6$127
Pacira Pharmaceuticals Incorporated4$108
Novartis6$108
Ferring Pharmaceuticals Inc.5$90
International Rehabilitative Sciences, Inc1$88
Bioventus LLC3$85
Avanir Pharmaceuticals, Inc.5$67
Medtronic(2 entities)4$63
Metacel Pharmaceuticals LLC2$58
Eisai Inc.2$48
Averitas Pharma Inc.2$43
Biodelivery Sciences International, Inc.3$43
Daiichi Sankyo Inc.2$35
Takeda Pharmaceuticals U.S.A., Inc.1$28
Avanos Medical1$28
Biogen1$17
Medline Industries LP1$16
DJO, LLC1$15
Vertex1$13
Athena Bioscience, LLC1$10

How this compares

$11,114 in reported general payments places this provider in the 95th percentile of 872 physical medicine & rehabilitation providers in New York.

See all physical medicine & rehabilitation providers in New York →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin11$237
Gabapentin21$209

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Queensbury

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →